Market Research Report Idiopathic Pulmonary Fibrosis Partnering Industry | Page 2

The report provides an analysis of partnering deals. The majority of deals are
discovery or development stage whereby the licensee obtains a right or an option
right to license the licensors technology. These deals tend to be multicomponent,
starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partners negotiated deals terms
provides critical insight into the negotiation process in terms of what you can expect
to achieve during the negotiation of terms. Whilst many smaller companies will be
seeking details of the payments clauses, the devil is in the detail in terms of how
payments are triggered contract documents provide this insight where press releases
do not.
This data driven report contains multiple links to online copies of actual deals and
contract documents as submitted to the Securities Exchange Commission by
companies and their partners, where available. Contract documents provide the
answers to numerous questions about a prospective partners flexibility on a wide
range of important issues, many of which will have a significant impact on each
partys ability to derive value from the deal.
The initial chapters of this report provide an orientation of partnering trends.
Chapter 1 provides an overview of the trends in partnering since 2010, including a
summary of deals by industry sector, stage of development, deal type, and
technology type.
Chapter 2 provides a review of the top 10 most active companies in the therapy area,
including a comprehensive listing of the deals announced by each company.